Glucagon-Like Peptide 1 Receptor Agonist Stimulation Inhibits Laser-Induced Choroidal Neovascularization by Suppressing Intraocular Inflammation.

Machida, Akira et al.·Investigative ophthalmology & visual science·2025·
RPEP-123822025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Glucagon-Like Peptide 1 Receptor Agonist Stimulation Inhibits Laser-Induced Choroidal Neovascularization by Suppressing Intraocular Inflammation.
Published In:
Investigative ophthalmology & visual science, 66(5), 15 (2025)
Database ID:
RPEP-12382

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-12382·https://rethinkpeptides.com/research/RPEP-12382

APA

Machida, Akira; Suzuki, Keiji; Nakayama, Takafumi; Miyagi, Sugao; Maekawa, Yuki; Murakami, Ryuya; Uematsu, Masafumi; Kitaoka, Takashi; Oishi, Akio. (2025). Glucagon-Like Peptide 1 Receptor Agonist Stimulation Inhibits Laser-Induced Choroidal Neovascularization by Suppressing Intraocular Inflammation.. Investigative ophthalmology & visual science, 66(5), 15. https://doi.org/10.1167/iovs.66.5.15

MLA

Machida, Akira, et al. "Glucagon-Like Peptide 1 Receptor Agonist Stimulation Inhibits Laser-Induced Choroidal Neovascularization by Suppressing Intraocular Inflammation.." Investigative ophthalmology & visual science, 2025. https://doi.org/10.1167/iovs.66.5.15

RethinkPeptides

RethinkPeptides Research Database. "Glucagon-Like Peptide 1 Receptor Agonist Stimulation Inhibit..." RPEP-12382. Retrieved from https://rethinkpeptides.com/research/machida-2025-glucagonlike-peptide-1-receptor

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.